Skip to main content
. 2022 Feb 24;11(5):788. doi: 10.3390/cells11050788

Table 3.

Prevalence and VAS score of olfactory dysfunctions in patients of group A and group B at time 0. Values are expressed as a percentage and mean and 95% CI. * p < 0.05.

Group A Group B p Values
Anosmia (n, %) 44 (27.2%) 118 (72.8%) <0.001 *
VAS score 8.02 (7.70–8.35) 2.63 (2.27–2.98)
Ageusia (n, %) 39 (88.6%) 1 (0.8%) <0.001 *
VAS score 7.43 (7.03–7.83) 2.47 (2.11–2.83)
Nasal obstruction (n, %) 8 (18.2%) 5 (4.2%) 0.007 *
VAS score 4.91 (4.19–5.63) 2.32 (1.94–2.70)
Rhinorrea (n, %) 0 (0%) 3 (2.5%) 0.286
VAS score 3.86 (3.35–4.38) 1.77 (1.42–2.12)
Postnasal drip (n, %) 0 (0%) 4 (3.4%) 0.216
VAS score 3.50 (3.00–4.00) 1.57 (1.11–1.92)
Sneezes (n, %) 1 (2.3%) 1 (0.8%) 0.465
VAS score 3.18 (2.61–3.75) 1.72 (1.40–2.04)
Headache (n, %) 11 (25%) 1 (0.8%) <0.001 *
VAS score 4.66 (3.86–5.45) 2.04 (1.67–2.41)